Dr. Carmen Chak-Lui Wong is currently an Associate Professor at the University of Hong Kong. She obtained her PhD degree in the University of Hong Kong and completed her post-doctoral training at the Johns Hopkins University. Her research team is devoted to unraveling the complex mechanisms that drive metabolic reprogramming and immune evasion in liver cancer. Her team employs precision mouse models to study these processes, enabling a deeper understanding of precision medicine for liver cancer. Her work has been published in PNAS, Gastroenterology, Journal of Hepatology, GUT, Hepatology, Science Advances, Nature Communications, Cell Reports, and the Journal of Clinical Investigation. She is the recipient of the National Natural Science Foundation of China Distinguished Young Scholars Fund, National Natural Science Foundation of China Excellent Young Scientists Fund (HK & Macau), RGC Research Fellow Scheme, Croucher Innovation Award, Outstanding Young Researcher Award of HKU, Outstanding Research Student Supervisor Award of HKU, Hong Kong Young Scientist Award, the Best PhD thesis Awards of HKU, Croucher Fellowship, University of British Columbia (Canada) Alumni Builder Award. She is an elected member of the Hong Kong Young Academy of Science. She is the co-editor-in-chief of Hepatology Communications (AASLD).